BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28922350)

  • 1. Stem cells and cell-based therapies for cerebral palsy: a call for rigor.
    Jantzie LL; Scafidi J; Robinson S
    Pediatr Res; 2018 Jan; 83(1-2):345-355. PubMed ID: 28922350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations.
    Ruff CA; Faulkner SD; Fehlings MG
    Dev Med Child Neurol; 2013 Aug; 55(8):689-97. PubMed ID: 23680015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review.
    Kiasatdolatabadi A; Lotfibakhshaiesh N; Yazdankhah M; Ebrahimi-Barough S; Jafarabadi M; Ai A; Sadroddiny E; Ai J
    Mol Neurobiol; 2017 Sep; 54(7):4963-4972. PubMed ID: 27520277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current proceedings of cerebral palsy.
    Fan HC; Ho LI; Chi CS; Cheng SN; Juan CJ; Chiang KL; Lin SZ; Harn HJ
    Cell Transplant; 2015; 24(3):471-85. PubMed ID: 25706819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-Analysis.
    Novak I; Walker K; Hunt RW; Wallace EM; Fahey M; Badawi N
    Stem Cells Transl Med; 2016 Aug; 5(8):1014-25. PubMed ID: 27245364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options.
    McDonald CA; Fahey MC; Jenkin G; Miller SL
    Pediatr Res; 2018 Jan; 83(1-2):333-344. PubMed ID: 28937975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.
    Romanov YA; Tarakanov OP; Radaev SM; Dugina TN; Ryaskina SS; Darevskaya AN; Morozova YV; Khachatryan WA; Lebedev KE; Zotova NS; Burkova AS; Sukhikh GT; Smirnov VN
    Cytotherapy; 2015 Jul; 17(7):969-78. PubMed ID: 25791070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action.
    Jiao Y; Li XY; Liu J
    Cell Transplant; 2019 May; 28(5):497-509. PubMed ID: 30384766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapy for neonatal brain injury: perspectives and challenges.
    Titomanlio L; Kavelaars A; Dalous J; Mani S; El Ghouzzi V; Heijnen C; Baud O; Gressens P
    Ann Neurol; 2011 Nov; 70(5):698-712. PubMed ID: 22162055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cord blood for brain injury.
    Sun JM; Kurtzberg J
    Cytotherapy; 2015 Jun; 17(6):775-785. PubMed ID: 25800775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neural progenitor cell transplantation in children with severe cerebral palsy.
    Luan Z; Liu W; Qu S; Du K; He S; Wang Z; Yang Y; Wang C; Gong X
    Cell Transplant; 2012; 21 Suppl 1():S91-8. PubMed ID: 22507684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential for cell-based therapy in perinatal brain injuries.
    Phillips AW; Johnston MV; Fatemi A
    Transl Stroke Res; 2013 Apr; 4(2):137-48. PubMed ID: 23814628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges.
    Peng X; Song J; Li B; Zhu C; Wang X
    J Neurosci Res; 2020 May; 98(5):815-825. PubMed ID: 31797400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for neonatal brain injury.
    Fleiss B; Guillot PV; Titomanlio L; Baud O; Hagberg H; Gressens P
    Clin Perinatol; 2014 Mar; 41(1):133-48. PubMed ID: 24524451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood-derived stem cells and brain repair.
    Sanberg PR; Willing AE; Garbuzova-Davis S; Saporta S; Liu G; Sanberg CD; Bickford PC; Klasko SK; El-Badri NS
    Ann N Y Acad Sci; 2005 May; 1049():67-83. PubMed ID: 15965108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of stem cells for preterm infant brain damage: Can we move from the heterogeneity of preclinical and clinical studies to established therapeutics?
    Passera S; Boccazzi M; Bokobza C; Faivre V; Mosca F; Van Steenwinckel J; Fumagalli M; Gressens P; Fleiss B
    Biochem Pharmacol; 2021 Apr; 186():114461. PubMed ID: 33571501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy.
    Bae SH; Kong TH; Lee HS; Kim KS; Hong KS; Chopp M; Kang MS; Moon J
    Cell Transplant; 2012; 21(11):2497-515. PubMed ID: 22524897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responding to requests of families for unproven interventions in neurodevelopmental disorders: hyperbaric oxygen "treatment" and stem cell "therapy" in cerebral palsy.
    Bell E; Wallace T; Chouinard I; Shevell M; Racine E
    Dev Disabil Res Rev; 2011; 17(1):19-26. PubMed ID: 22447751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy community.
    Smith MJ; Finch-Edmondson M; Miller SL; Webb A; Fahey MC; Jenkin G; Paton MCB; McDonald CA
    Stem Cell Res Ther; 2023 Feb; 14(1):18. PubMed ID: 36737828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury.
    Verina T; Fatemi A; Johnston MV; Comi AM
    Pediatr Neurol; 2013 May; 48(5):346-54. PubMed ID: 23583051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.